Apply for HealthTech Online Pitching

April 21, 2020

l

Satu Peltonen

Beijing sky scraper & cctv tower

Apply for Reboot the Future HealthTech Online Pitching to Venture Capital Investors with Slush China by scanning the code on the image above or using the link for registration.

Take a note on the important dates!

Apply for Reboot the Future – HealthTech Online Pitching to Venture Capital Investors with Slush China.

On 22nd May an online pitching for HealthTech Startups is organized by inXso together with Slush China to Venture Capital investors of which there is a significant participation from the Chinese Venture Capital investment companies focused on HealthTech, BioPharma and BioMedTech.

This is a great opportunity to seek investors insights and build collaboration towards Chinese markets. The jury will select the three best startups to present their innovation together with three Chinese startups to a publicum of 400 different entrepreneurs, investors and company representatives around the world in a virtual event that is location-independent.

Chinese healthcare market is the second largest in the World and the local investors and partners are eager to work with European companies. Succeeding in the markets needs particular knowledge of the local regulations, business model adjusting and understanding of networking in Chinese cultural contexts.

The Health Tech online pitching is co-organized by inXso and introduces Chinese Health Tech market, business model cases and regulative aspects. After the online pitching event Health Tech Track will continue to help members in improving the investor and the startup community relations in China.

The invitation to Reboot the future HealthTech online pitching  is open for startup companies to apply globally and we primarily focus on teams in incubators. We aim to build a virtual co-working space for the interest group to learn together cross nations on startup development and launching business in international markets.

Important dates:

1st May: Registration opens for Startups

10th May: End of registration for Startups

22nd May: Online pitching

 

Link to registration:

http://slushchina.mikecrm.com/AyVxhye

Life Science & Medical Technology EXPO’s in Asia 2022 – Where you should start

Expos, trade fairs, and shows are a way to build business networks and search for partners that open new potential markets. It brings a lot of positive exposure for companies and their innovations, builds customer interest, and opens doors for collaborative projects along the life science and medical technology value chain.

Horizon Europe Cluster Health – Research and Innovation Funding

The EU Research and Innovation Programme 2021-2027 has gathered a lot of attention from the research communities around Europe this time around with their Cluster Health topics that are open for proposals. The published destinations aim to address acute and long-term problems in the healthcare ecosystem and the health and well-being of citizens from a societal point of view – without forgetting the lessons learned from the Covid-19 pandemic.

inXso 2021 MedTech Series – R&D focal points

For 2021 inXso has created a webinar series outlining some specific features that are essential for global design of medical technology, and introduces some regulatory aspects in context of EU MDR and Swiss regulatory landscape, as well as some basic features from Chinese and Japanese regulations that everyone – or every company – considering these healthcare markets should now of.

How to build internationalization strategy for HealthTech

It is a known fact that most internationalization attempts fail due to lack of thorough preparation and adhering to the chosen strategy.

When it comes to life sciences – healthcare technology, biomedical technology and pharmaceuticals – that is an industry operating in a heavily regulated environment, any attempt to seek market growth through internationalization faces a multitude of specific considerations.

User-Centered Design of Medical Devices

In recent years medical technology has taken a trend towards creating personalized care while seeking ways to enhance quality for patients and to lower healthcare costs. At the same time developers have to keep in mind the ease of use of the devices and gaining regulatory approval for them in the highly internationalized market.

The Internationalization Challenge of Biomedical Innovations

The life science industry distinguishes itself from other high-technology industries with such fundamental dimensions as applying scientific knowledge to provide technological solutions aiming to improve health care and quality of life – in a highly regulated environment. At the same time, usually purchasing decisions are not made by end-consumers, but their physicians or such third party as an insurance company, for example.

Apply for HealthTech Online Pitching

On 22nd May an online pitching for HealthTech Startups is organized by inXso together with Slush China to Venture Capital investors of which there is a significant participation from the Chinese Venture Capital investment companies focused on HealthTech, BioPharma and BioMedTech.

What are the Key Points of Chinese Health Tech Initiatives – Join Discussion on May 29th

What are we discussing? In our series focusing on Health Tech in Chinese market inXso is organizing an interactive webinar “Health Tech China Focus” together with Tampere HealthHUB that will briefly discuss some of the key points and rather unique aspects of Chinese...